Axonics

Axonics Net Debt per Share

The Net Debt per Share of Axonics (AXNX) as of Nov 19, 2026 is -7.03 USD. In the previous year, Net Debt per Share was -7.28 USD — a change of -3.43% (higher).

Net Debt per Share

-7.03USD

YoY

-3.43%

Last updated:

Net Debt per Share of Axonics is 2023 -7.03 USD. Net Debt per Share of Axonics was 2022 -7.28 USD. It decreases by -3.43% higher compared to the previous year.

The Axonics Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2016
-0.16 USD
Jan 1, 2017
-0.50 USD
Jan 1, 2018
-2.73 USD
Jan 1, 2019
-3.33 USD
Jan 1, 2020
-4.48 USD
Jan 1, 2021
-4.50 USD
Jan 1, 2022
-7.28 USD
Jan 1, 2023
-7.03 USD
The Axonics Net Debt per Share history
YEARNet Debt per ShareYoY
-7.03USD-3.43%
-7.28USD+61.72%
-4.50USD+0.36%
-4.48USD+34.71%
-3.33USD+21.90%
-2.73USD+451.59%
-0.50USD+207.23%
-0.16USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

Net Debt per Share of Axonics is -7.03 USD in 2023.

Net Debt per Share of Axonics changed from -7.28 USD to -7.03 USD, representing a -3.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Axonics since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Axonics

All Key Metrics — Axonics